Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dominion Energy
D
|
+$10.5M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$8.19M |
| 3 |
NXP Semiconductors
NXPI
|
+$7.89M |
| 4 |
Occidental Petroleum
OXY
|
+$7.78M |
| 5 |
FedEx
FDX
|
+$6.82M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$37.2M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$21.8M |
| 3 |
Amazon
AMZN
|
+$17.7M |
| 4 |
Quanta Services
PWR
|
+$15.2M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$13.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.25% |
| 2 | Consumer Discretionary | 15.93% |
| 3 | Industrials | 14.92% |
| 4 | Healthcare | 12.91% |
| 5 | Consumer Staples | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
LPL Financial
LPLA
$28.5B
| $270K | 0.01% |
+1,898
| New | +$242K |
|
877
Glaukos
GKOS
$10.9B
| $269K | 0.01% |
+3,208
| New | +$282K |
|
|
FRTA
878
DELISTED
Forterra, Inc
FRTA
| $269K | 0.01% |
11,559
-1,839
| -14% | -$39.6K |
|
879
RBC Bearings
RBC
$16B
| $265K | 0.01% |
1,348
-1,117
| -45% | -$210K |
|
880
SFL Corp
SFL
$1.65B
| $265K | 0.01% |
33,029
+13,502
| +69% | +$100K |
|
|
SC
881
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $265K | 0.01% |
+9,801
| New | +$246K |
|
|
MRTX
882
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $259K | 0.01% |
1,514
| – | – |
|
|
SF
883
Stifel
SF
$12.2B
| $258K | 0.01% |
+6,053
| New | +$236K |
|
884
Goodyear
GT
$1.72B
| $257K | 0.01% |
+14,637
| New | +$212K |
|
885
Domino's
DPZ
$11.3B
| $256K | 0.01% |
+695
| New | +$256K |
|
886
Allegiant Air
ALGT
$2.24B
| $255K | 0.01% |
+1,045
| New | +$232K |
|
887
Pacific Biosciences
PACB
$420M
| $254K | 0.01% |
+7,633
| New | +$267K |
|
888
Globus Medical
GMED
$11.7B
| $253K | 0.01% |
4,110
-2,415
| -37% | -$153K |
|
889
St. Joe Company
JOE
$3.92B
| $251K | 0.01% |
5,862
+427
| +8% | +$20.4K |
|
890
Century Aluminum
CENX
$4.35B
| $248K | 0.01% |
14,063
-12,129
| -46% | -$173K |
|
891
Brinker International
EAT
$10.6B
| $246K | 0.01% |
3,458
-19,059
| -85% | -$1.27M |
|
892
Freedom Holding
FRHC
$10.9B
| $245K | 0.01% |
+4,586
| New | +$241K |
|
893
Maravai LifeSciences
MRVI
$1.29B
| $244K | 0.01% |
+6,858
| New | +$227K |
|
|
CLDR
894
DELISTED
Cloudera, Inc.
CLDR
| $244K | 0.01% |
20,032
-42,566
| -68% | -$636K |
|
|
AL
895
DELISTED
Air Lease Corp
AL
| $242K | 0.01% |
+4,942
| New | +$225K |
|
896
Gogo Inc
GOGO
$363M
| $241K | 0.01% |
+24,939
| New | +$296K |
|
897
1-800-Flowers.com
FLWS
$254M
| $240K | 0.01% |
8,688
-4,954
| -36% | -$147K |
|
898
Ingles Markets
IMKTA
$1.61B
| $240K | 0.01% |
3,888
-3,134
| -45% | -$164K |
|
899
Moderna
MRNA
$57.9B
| $240K | 0.01% |
1,829
-3,962
| -68% | -$574K |
|
900
MSCI
MSCI
$41B
| $240K | 0.01% |
+573
| New | +$241K |
|
Similar funds
Joel Greenblatt's Q1 2021 Portfolio in Review
As of Q1 2021, Joel Greenblatt held 1,161 positions worth $2.24B, down 26% from $3.02B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Joel Greenblatt withdrew a net $1.04B in Q1 2021, closing 182 positions and reducing 614 holdings. Its most notable exit was Novavax, an estimated $9.66M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Joel Greenblatt opened a new position in Becton Dickinson worth $5.64M.
- Joel Greenblatt's largest Q1 2021 buy was Becton Dickinson: 23,757 shares worth $5.64M.
- Joel Greenblatt added most to Dominion Energy in Q1 2021, an estimated $10.5M increase.
- Joel Greenblatt's biggest Q1 2021 reduction was Apple, cutting an estimated $37.2M.
- Joel Greenblatt fully exited Novavax in Q1 2021, selling an estimated $9.66M.
- Joel Greenblatt's ten largest holdings make up 12% of its $2.24B portfolio in Q1 2021.
- Joel Greenblatt opened 177 new positions and closed 182 in Q1 2021.
- Joel Greenblatt's portfolio value fell 26% quarter-over-quarter to $2.24B.
Based on Gotham Asset Management's 13F filing for Q1 2021, filed 17 May 2021.